CT Based Assessment of Sarcopenia and Its Association With Biologic Treatment Outcomes in Inflammatory Bowel Disease Patients
Observational · No treatment assigned · Sites not listed yet · Assiut University
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: CT-Assessed Sarcopenia Outcomes. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 to 60
- Any sex
- Healthy volunteers accepted
Some of the main requirements, copied from the record:
- Patient above age of 18 years old
- diagnosed to have IBD through: clinical features, endoscopic findings
- received biological therapy
There are also 4 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 50 participants are expected to take part.
- Start date: 2026-05-01 (planned).
- Main results expected around 2027-05-01 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Main thing being measured
- Incidence of Sarcopenia in Inflammatory Bowel Disease Patients (At base line)
In the researchers’ words
Our study aims to investigate the incidence of sarcopenia in Patients with IBD using CT-based body composition parameters, observe the interaction between sarcopenia and IBD treatment, and determine whether sarcopenia affects the response to biologic therapies
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | CT-Assessed Sarcopenia Outcomes |
| Lead sponsor | Assiut University |
| Enrollment | 50 (estimated) |
| Start date | 2026-05-01 |
| Primary completion (est.) | 2027-05-01 |
| First posted | 2026-03-19 |
| Last updated | 2026-03-20 |
| Official title | CT Based Assessment of Sarcopenia and Its Association With Biologic Treatment Outcomes in Inflammatory Bowel Disease Patients |
| ClinicalTrials.gov ID | NCT07482163 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Patient above age of 18 years old * diagnosed to have IBD through: clinical features, endoscopic findings * received biological therapy Exclusion Criteria: * Patients with UC who are under age of 18 years old. * Pregnancy. * Previous colectomy. * Patient refuse to participate in the study
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.